Genomma Tries To Force Prestige Takeover By Seeking Board Posts
This article was originally published in The Tan Sheet
Executive Summary
Genomma intends to seek a large board presence after Prestige Brands on March 12 rejected its unsolicited bid of $16.60 a share, an offer Prestige said was “well below the intrinsic value of the firm,” and plagued with other problems, including unsecured finances.
You may also be interested in...
In Brief
Novartis makes OTC exec change following recall and plant shutdown; Prestige Brands adopts plan to deter Genomma takeover bid; Pfizer scoops up Emergen-C maker Alacer; CSPI threatens Amway with Nutrilite suit; more news In Brief.
Prestige Acquires 17 Glaxo OTC Brands, Enters Analgesics Market
Prestige Brands acquires GlaxoSmithKline’s BC and Goody’s analgesic brands as part of $660 million deal for 17 North American OTC lines, also including Beano gas treatment, FiberChoice supplement and Sominex sleep aid.
Sanofi Enters India’s Consumer Market With Universal Medicare Buy
Sanofi’s search for high-growth consumer brands in India led to the firm’s Aug. 24 acquisition of Universal Medicare Pvt. Ltd.’s nutraceutical business.